Oppenheimer & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-65,713
Closed -$6.53M 1359
2019
Q3
$6.53M Sell
65,713
-36,753
-36% -$3.65M 0.18% 131
2019
Q2
$9.47M Sell
102,466
-36,580
-26% -$3.38M 0.26% 83
2019
Q1
$13.1M Buy
139,046
+7,554
+6% +$713K 0.35% 62
2018
Q4
$8.43M Sell
131,492
-19,464
-13% -$1.25M 0.26% 86
2018
Q3
$13.5M Buy
150,956
+26,591
+21% +$2.38M 0.34% 62
2018
Q2
$9.88M Sell
124,365
-8,117
-6% -$645K 0.27% 82
2018
Q1
$11.8M Sell
132,482
-11,618
-8% -$1.04M 0.3% 73
2017
Q4
$15M Sell
144,100
-11,773
-8% -$1.23M 0.39% 55
2017
Q3
$22.7M Buy
155,873
+24,482
+19% +$3.57M 0.61% 26
2017
Q2
$17.1M Buy
131,391
+12,194
+10% +$1.58M 0.47% 38
2017
Q1
$14.8M Buy
119,197
+23,471
+25% +$2.92M 0.42% 49
2016
Q4
$11.1M Sell
95,726
-5,774
-6% -$668K 0.32% 70
2016
Q3
$10.6M Buy
101,500
+7,640
+8% +$799K 0.31% 72
2016
Q2
$9.26M Sell
93,860
-1,539
-2% -$152K 0.28% 85
2016
Q1
$9.55M Sell
95,399
-3,587
-4% -$359K 0.29% 82
2015
Q4
$11.9M Sell
98,986
-3,552
-3% -$425K 0.35% 64
2015
Q3
$11.1M Sell
102,538
-9,914
-9% -$1.07M 0.34% 61
2015
Q2
$13M Sell
112,452
-2,553
-2% -$295K 0.36% 56
2015
Q1
$13.3M Buy
115,005
+8,212
+8% +$947K 0.36% 59
2014
Q4
$11.9M Sell
106,793
-3,281
-3% -$367K 0.34% 64
2014
Q3
$10.4M Buy
110,074
+6,605
+6% +$626K 0.31% 67
2014
Q2
$8.89M Buy
103,469
+13,021
+14% +$1.12M 0.27% 85
2014
Q1
$6.31M Buy
90,448
+30,946
+52% +$2.16M 0.19% 128
2013
Q4
$5.03M Sell
59,502
-1,792
-3% -$151K 0.16% 157
2013
Q3
$4.72M Buy
61,294
+4,318
+8% +$333K 0.17% 158
2013
Q2
$3.33M Buy
+56,976
New +$3.33M 0.13% 196